# Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes

> **NCT00754689** · PHASE3 · WITHDRAWN · sponsor: **Sanofi**

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Rimonabant
- **DRUG:** Metformin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00754689
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-09
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company decision taken in light of demands by certain national health authorities
- **Last updated:** 2016-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00754689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00754689, "Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00754689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*